Aurobindo Pharma | ARBP - Interest Expense On Debt

Stock Price
1,164.15
Daily Change
-48.15 -3.97%
Monthly
-3.58%
Yearly
3.30%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR952.4M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Cipla INR 140.3M 8.5M Dec/2025
Divis Laboratories Ltd INR 30M 20M Jun/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Hindustan Unilever INR 1.29B 490M Sep/2025
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
UPL INR 7.53B 170M Sep/2025